News
Biannually-injected hydrogel could keep glaucoma at bay
December 8, 2020 /
Presently, glaucoma is treated via daily-administered eye drops, surgery, or implanted devices – none of which are guaranteed to be successful. In the future, however, it’s possible that a twice-yearly injection could do the trick.
MATR Supporters (view all)
Posted in: Incubators and R&D, Cool Stuff That's Coming
Sorry, we couldn't find any posts. Please try a different search.